奥沙利铂联合紫彬醇方案治疗晚期胃癌的20例临床观察(2)
 |
| 第1页 |
参见附件(1769KB，2页)。
参 考 文 献
[1] 魏昌华,姚春芳,恽榴红,等.新型抗癌药2紫杉醇.中国药学杂志,1996,31(5):259-262.
[2] Hainsworth JD ,Burris HA ,Erland JB ,et al . Phase I study of docetaxol administered by weekly infusion inpatients with advanced refractory cancer. J Clin oncol ,1998 ,16 :2164 - 2168.
[3] 陈凌翔,陈嘉,黄富麟.紫杉醇每周疗法治疗晚期恶性肿瘤30例.肿瘤学杂志,2001,7(1):35.
[4] 梅家转,王华庆,牛红蕊.紫杉醇联合顺铂、醛氢叶酸及氟脲嘧啶治疗32例晚期胃癌.中国癌症杂志,2001,11(5):476.
[5] 汪竹,刘晓丹,童建东.泰索帝联合顺铂和52氟脲嘧啶治疗晚期胃癌的疗效观察.药学进展,2002,26(1):36-38.
[6] Kim YH ,Shin SW,Kim BS ,et al. Paclitaxel ,52Fu and cisplatin combi2 nation chemotherapy for the treatment of advanced gastric carcinoma. J Cancer ,1999,85(2):295-300.
[7] Gourdier I,Crabbe L, Andreau K, et al.Oxalipatin-induced mitochondrial apoptotic response of colon carcinoma cells does not require nuclear DNA Oncogene,2004,23(45):7449-7457.
[8] De Vita F,Orditura M,Matano E,et al.A phase II study of biweekly Oxaliplatin plus infusional 5-fluorouracil and folinic acid(FOLFOX-4) as First-line treatment of advanced gastric cancer patients. Br J Cancer,2005,92(9):1644-1649.
[9] Al-Batran SE,Atmaca A,Hegewisch-Becker S,et al.Phase II trial of biweekly infusional fluorouracil,folinic acid,and oxaliplatin in patients with advanced gastric cancer.Clin Oncol,2004,22(4):658-663.
您现在查看是摘要介绍页，详见PDF附件(1769KB，2页)。